▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Viz.ai Announces Collaboration With Sanofi and Regeneron to Improve Management and Care of Chronic Obstructive Pulmonary Disease (COPD)

#ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year partnership with Sanofi (NASDAQ: SNY), an innovative global healthcare company, ...

Business Wire

Companies will collaborate on an AI-powered care improvement solution for patients with high-risk COPD

SAN FRANCISCO: #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year partnership with Sanofi (NASDAQ: SNY), an innovative global healthcare company, and Regeneron (NASDAQ: REGN), a leading biotechnology company, to deploy and evaluate an AI-powered workflow solution for chronic obstructive pulmonary disease (COPD). With support from Sanofi and Regeneron, Viz.ai will investigate the use of the Viz COPD module, a care acceleration solution that will leverage electronic health record (EHR) data and artificial intelligence (AI) to advance the detection and management of high-risk COPD patients.

"At Sanofi, we’re excited to collaborate with Viz.ai to further address unmet needs in COPD care by leveraging AI," said Paul Rowe, MD, ATSF & Head of Medical, Specialty Care at Sanofi. “With this collaboration, we will study the impact of the Viz COPD module, a streamlined AI-enabled EHR workflow to improve access to care and ultimately patient outcomes in COPD, a disease that remains underprioritized, underfunded and undertreated in comparison to other noncommunicable diseases.”

COPD is a common, progressive lung disease that results in restricted airflow, making it difficult to breathe. There are an estimated 392 million people living with COPD globally,1 and it is the fourth leading cause of death worldwide.2 Furthermore, COPD adds significant strain to healthcare systems and with each case, healthcare utilization grows as symptoms progress, magnifying the economic toll of the disease. Many COPD patients fail to receive optimal treatment due to improper identification of risk level, poor care coordination, lack of monitoring and escalation, and high administrative barriers to therapy.3,4

The Viz COPD module will evaluate EHR data using natural language processing to screen and triage patients in line with established clinical guidelines, flagging high-risk individuals for further follow-up and care. The Viz COPD module builds upon Viz.ai's presence in over 1,700 hospitals and health systems with over 60,000 healthcare providers on the platform to improve diagnosis and care across a range of disease areas, including the respiratory space. Together, Viz.ai, Sanofi, and Regeneron aim to maximize patient impact, particularly for patients who stand to benefit most from improved follow-up and care.

“This collaboration with Sanofi and Regeneron is a major step forward in our mission to expand AI-driven care coordination across disease areas with critical unmet needs, such as COPD,” said Chris Mansi, MD, CEO and co-founder of Viz.ai. “Our approach aims to empower healthcare providers to deliver data-driven, guideline-directed care that meaningfully impacts patient outcomes. We look forward to collaborating with Sanofi and Regeneron to harness AI to accelerate advancements in disease management and improve patient access to care.”

About Viz.ai, Inc.

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,700+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai One® is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit Viz.ai.

References

1 World Health Organization. (2023, November 15). Smoking is the leading cause of chronic obstructive pulmonary disease. World Health Organization. Retrieved November 14, 2024 from https://www.who.int/news/item/15-11-2023-smoking-is-the-leading-cause-of-chronic-obstructive-pulmonary-disease

2 World Health Organization. (n.d.). Chronic obstructive pulmonary disease (COPD). World Health Organization. Retrieved November 14, 2024 from https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-%28copd%29

3 Siu DCH, Gafni-Lachter L. Addressing Barriers to Chronic Obstructive Pulmonary Disease (COPD) Care: Three Innovative Evidence-Based Approaches: A Review. Int J Chron Obstruct Pulmon Dis. 2024;19:331-341. Published 2024 Feb 1. doi:10.2147/COPD.S426050

4 Pierucci P, Santomasi C, Ambrosino N, Portacci A, Diaferia F, Hansen K, Odemyr M, Jones S, Carpagnano GE. Patient's treatment burden related to care coordination in the field of respiratory diseases. Breathe (Sheff). 2021 Mar;17(1):210006. doi: 10.1183/20734735.0006-2021. PMID: 34295410; PMCID: PMC8291948.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Mastercard Incorporated to Host Information Session on Agentic Commerce…

On Monday, July 14, 2025 at 10:00 a.m. Eastern Time, Mastercard Incorporated (NYSE: MA) will host a session to explore Mastercard’s recent announcements…

Wave Function™ and Packsmith.ai: Redefining E-Commerce with AI Logistics

#3PL--Wave Function™, a New Bedford, MA-based founding partnership company, has invested in Packsmith.ai, a Los Angeles-based, AI-driven third-party logistics…

AI Unicorn EvenUp Opens New San Francisco Headquarters to Catalyze Growth…

#AI--EvenUp, the highest-funded AI technology company serving personal injury law firms, has officially opened its new headquarters at 353 Sacramento…

Amazon Prime Day 2025 Delivers Record Sales and Savings in Expanded Four-Day…

Amazon announced today that Prime Day 2025 was its biggest Prime Day event ever and that customers saved billions on deals across more than 35 product…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!